Across TCGA pan-cancer cohorts, RNU6-71P RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated RNU6-71P data layer.
The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RNU6-71P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-71P expression acts as an unfavorable survival marker.
LIHC are the cancer types where RNU6-71P RNA most reproducibly stratifies survival.